A detailed history of Daiwa Securities Group Inc. transactions in Alector, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 277 shares of ALEC stock, worth $1,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares
277
Previous 277 -0.0%
Holding current value
$1,360
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

BUY
$21.65 - $39.49 $2,771 - $5,054
128 Added 85.91%
277 $6,000
Q4 2020

Feb 04, 2021

SELL
$9.4 - $16.7 $2,716 - $4,826
-289 Reduced 65.98%
149 $2,000
Q1 2020

May 14, 2020

BUY
$16.25 - $35.28 $796 - $1,728
49 Added 12.6%
438 $11,000
Q4 2019

Jan 31, 2020

BUY
$14.17 - $20.3 $5,512 - $7,896
389 New
389 $7,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $405M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.